Across TCGA pan-cancer cohorts, CDY15P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated CDY15P data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CDY15P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY15P expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.
STAD, KIRP, and LGG are the cancer types where CDY15P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.